These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 8104093)
1. Estrogen receptor, progesterone receptor, and HER-2/neu protein in breast cancers from pregnant patients. Guinee VF; Hess KR Cancer; 1993 Oct; 72(7):2291-2. PubMed ID: 8104093 [No Abstract] [Full Text] [Related]
2. Estrogen receptor, progesterone receptor, and HER-2/neu protein in breast cancers from pregnant patients. Elledge RM; Ciocca DR; Langone G; McGuire WL Cancer; 1993 Apr; 71(8):2499-506. PubMed ID: 8095853 [TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical analysis of estrogen and progesterone receptor and neu expression in breast carcinoma. Chu JS; Lee WJ; Chen KM; Hsu HC J Formos Med Assoc; 1994 Apr; 93(4):277-82. PubMed ID: 7914767 [TBL] [Abstract][Full Text] [Related]
4. HER-2/neu oncogene protein and prognosis in breast cancer. Tandon AK; Clark GM; Chamness GC; Ullrich A; McGuire WL J Clin Oncol; 1989 Aug; 7(8):1120-8. PubMed ID: 2569032 [TBL] [Abstract][Full Text] [Related]
5. Diminished ratio of estrogen receptors to progesterone receptors in breast carcinomas of women who have had multiple miscarriages. Lehrer S; Levine E; Savoretti P; Cropley J; Dalton J; Song HK; Thung SN; Rabinowitz J; Mandell L Mt Sinai J Med; 1992 Jan; 59(1):28-31. PubMed ID: 1734234 [TBL] [Abstract][Full Text] [Related]
6. Increased natural killer cell activity correlates with low or negative expression of the HER-2/neu oncogene in patients with breast cancer. Wiltschke C; Tyl E; Speiser P; Steininger A; Zeillinger R; Kury F; Czerwenka K; Kubista E; Preis P; Krainer M Cancer; 1994 Jan; 73(1):135-9. PubMed ID: 7903907 [TBL] [Abstract][Full Text] [Related]
7. Correlation of hormone receptors with Her-2 Neu protein expression and the histological grade in invasive breast cancers in a cohort of Saudi Arabia. Arafah M Turk Patoloji Derg; 2012; 28(1):38-43. PubMed ID: 22207430 [TBL] [Abstract][Full Text] [Related]
8. Expression of HER-2/neu oncoprotein in human breast cancer: a comparison of immunohistochemical and western blot techniques. Molina R; Ciocca DR; Tandon AK; Allred DC; Clark GM; Chamness GC; Gullick WJ; McGuire WL Anticancer Res; 1992; 12(6B):1965-71. PubMed ID: 1363511 [TBL] [Abstract][Full Text] [Related]
9. Expression of Her-2/neu oncogene protein product and epidermal growth factor receptors in surgical specimens of human breast cancers. Moe RE; Moe KS; Porter P; Gown AM; Ellis G; Tapper D Am J Surg; 1991 May; 161(5):580-3. PubMed ID: 1674411 [TBL] [Abstract][Full Text] [Related]
10. Re: Quantitative association between HER-2/neu and steroid hormone receptors in hormone receptor-positive primary breast cancer. Spyratos F; Bouchet C; Ferrero-Poüs M; Tubiana-Hulin M; Hacène K J Natl Cancer Inst; 2003 Sep; 95(18):1417-8; author reply 1418. PubMed ID: 13130118 [No Abstract] [Full Text] [Related]
11. [Sex hormone receptor in meningioma]. Kuratsu J; Matsukado Y Neurol Med Chir (Tokyo); 1982 Dec; 22(12):1009-13. PubMed ID: 6188967 [No Abstract] [Full Text] [Related]
12. [Immunohistochemical research on breast cancer cell proliferation and hormonal receptor status with special emphasis on HER-2/neu expression]. Ohlinger R; Steffen SM; Oellig F; Köhler G; Schwesinger G; Lorenz G Zentralbl Gynakol; 2002 Oct; 124(10):473-7. PubMed ID: 12712389 [TBL] [Abstract][Full Text] [Related]
13. Quantitative association between HER-2/neu and steroid hormone receptors in hormone receptor-positive primary breast cancer. Konecny G; Pauletti G; Pegram M; Untch M; Dandekar S; Aguilar Z; Wilson C; Rong HM; Bauerfeind I; Felber M; Wang HJ; Beryt M; Seshadri R; Hepp H; Slamon DJ J Natl Cancer Inst; 2003 Jan; 95(2):142-53. PubMed ID: 12529347 [TBL] [Abstract][Full Text] [Related]
14. Clinical significance of HER-2/neu oncogene amplification in primary breast cancer. The South Australian Breast Cancer Study Group. Seshadri R; Firgaira FA; Horsfall DJ; McCaul K; Setlur V; Kitchen P J Clin Oncol; 1993 Oct; 11(10):1936-42. PubMed ID: 8105035 [TBL] [Abstract][Full Text] [Related]
15. Multivariable analysis of DNA ploidy, p53, and HER-2/neu as prognostic factors in endometrial cancer. Lukes AS; Kohler MF; Pieper CF; Kerns BJ; Bentley R; Rodriguez GC; Soper JT; Clarke-Pearson DL; Bast RC; Berchuck A Cancer; 1994 May; 73(9):2380-5. PubMed ID: 7909491 [TBL] [Abstract][Full Text] [Related]
16. Association between HER-2/neu and the progesterone receptor in oestrogen-dependent breast cancer is age-related. Huang HJ; Neven P; Drijkoningen M; Paridaens R; Wildiers H; Van Limbergen E; Berteloot P; Amant F; Christiaens MR; Vergote I Breast Cancer Res Treat; 2005 May; 91(1):81-7. PubMed ID: 15868434 [TBL] [Abstract][Full Text] [Related]
17. Tissue microarray (TMA) versus whole section immunohistochemistry in the assessment of ER/PR and Her-2/neu status in a breast cancer series from Sudan. Awadelkarim KD; Arizzi C; Elamin EO; Osman I; Mekki SO; Biunno I; Barberis MC; Mariani-Costantini R Breast J; 2013; 19(4):446-7. PubMed ID: 23721068 [No Abstract] [Full Text] [Related]